Țară: Canada
Limbă: engleză
Sursă: Health Canada
BETA-CAROTENE; VITAMIN B1 (THIAMINE MONONITRATE); VITAMIN B2 (RIBOFLAVIN); NICOTINAMIDE; D-PANTOTHENIC ACID (CALCIUM PANTOTHENATE); VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE); ASCORBIC ACID (ASCORBIC ACID); VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE); COPPER (COPPER GLUCONATE); IODINE (POTASSIUM IODIDE); IRON (FERROUS FUMARATE); MAGNESIUM (MAGNESIUM OXIDE); ZINC (ZINC OXIDE); FOLIC ACID; VITAMIN B12 (CYANOCOBALAMIN); VITAMIN D3 (CHOLECALCIFEROL); CALCIUM (CALCIUM CARBONATE)
JAMP PHARMA CORPORATION
B03AE04
IRON, MULTIVITAMINS AND MINERALS
1.6MG; 3MG; 3.4MG; 20MG; 5MG; 10MG; 120MG; 13.8MG; 2MG; 0.15MG; 35MG; 50MG; 15MG; 1.1MG; 12MCG; 600UNIT; 300MG
TABLET
BETA-CAROTENE 1.6MG; VITAMIN B1 (THIAMINE MONONITRATE) 3MG; VITAMIN B2 (RIBOFLAVIN) 3.4MG; NICOTINAMIDE 20MG; D-PANTOTHENIC ACID (CALCIUM PANTOTHENATE) 5MG; VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE) 10MG; ASCORBIC ACID (ASCORBIC ACID) 120MG; VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE) 13.8MG; COPPER (COPPER GLUCONATE) 2MG; IODINE (POTASSIUM IODIDE) 0.15MG; IRON (FERROUS FUMARATE) 35MG; MAGNESIUM (MAGNESIUM OXIDE) 50MG; ZINC (ZINC OXIDE) 15MG; FOLIC ACID 1.1MG; VITAMIN B12 (CYANOCOBALAMIN) 12MCG; VITAMIN D3 (CHOLECALCIFEROL) 600UNIT; CALCIUM (CALCIUM CARBONATE) 300MG
ORAL
15G/50G
Prescription
Active ingredient group (AIG) number: 1747661005; AHFS:
APPROVED
2023-02-22
_ Pregnancy Multivitamin Product Monograph_ _ Page 1 of 30_ PRODUCT MONOGRAPH PR PREGNANCY MULTIVITAMIN Vitamin-Mineral Supplement Tablets for Prenatal/Postpartum Use Oral, Blue Tablet (evening) contains 1.1 mg of Folic Acid Multivitamins and other Minerals Including Combinations JAMP Pharma Corporation 1310 rue Nobel Boucherville, Quebec J4B 5H3, Canada Control No.: 252149 Date of Revision: February 22, 2023 _ Pregnancy Multivitamin Product Monograph_ _ Page 2 of 30_ TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION ......................................................... 3 SUMMARY PRODUCT INFORMATION ............................................................................................................... 3 INDICATIONS AND CLINICAL USE .................................................................................................................... 4 CONTRAINDICATIONS ......................................................................................................................................... 4 WARNINGS AND PRECAUTIONS ........................................................................................................................ 4 ADVERSE REACTIONS .......................................................................................................................................... 6 DRUG INTERACTIONS ........................................................................................................................................ 10 DOSAGE AND ADMINISTRATION .................................................................................................................... 15 OVERDOSAGE ...................................................................................................................................................... 16 ACTION AND CLINICAL PHARMACOLOGY ................................................................................................... 17 STORAGE AND STABILITY ........................................................................... Citiți documentul complet